Emulate, Inc.

Emulate is the pioneer of Organ-on-a-Chip technology, enabling researchers to generate human-relevant data that advance safer, more effective therapies.

[Emulate, Inc. @emulateinc]

ICYMI: This month, we heralded in the future of human-centric drug development with the launch of the AVA Emulation System, a first-of-its-kind high-throughput Organ-Chip platform. https://t.co/jLIZyiRE5U

[NASA @NASA]

It's not just a phase 🌕

Artemis II astronauts captured these views of the Moon as the Orion spacecraft flew around the far side of the Moon on April 6, 2026.

[Emulate, Inc. @emulateinc]

🧠 Introducing Brain-Chip R1 — the first isogenic, five-cell Organ-Chip model of the human NVU.

A ready-to-use system for BBB transport + neuroinflammation research with results in 12 days.

Learn more 👉 https://t.co/LqZateiRZ2

#OrganChips #BBB #CNSResearch

[Emulate, Inc. @emulateinc]

What if we could predict a patient’s treatment response before they receive it? Organ-on-a-Chip technology offers a home away from home for patient-derived samples—revealing how cells truly respond to therapy.

Full story 👉 https://t.co/UbsoEh0zdC

#PersonalizedMedicine

[Emulate, Inc. @emulateinc]

Join us for a live webinar where Dr. Ferri and Dr. Ingber will present the data and discuss what this means for the future of personalized medicine.
🗓️ October 30th, 2025 at 11:00 am EDT
🔗 Register: https://t.co/hxk7oTbGNm

#OrganChip #PersonalizedMedicine #NAMs

[Emulate, Inc. @emulateinc]

Predicting how each individual patient will respond to cancer therapy has long been the holy grail of personalized medicine.

A new study co-led by Dr. Lorenzo Ferri (McGill University) and Dr. Donald Ingber (Wyss Institute, Harvard) could change that. 👇

[Emulate, Inc. @emulateinc]

This breakthrough marks a major step toward functional precision medicine, where treatment decisions are guided by human-relevant models that mirror each patient’s unique biology.

And it could revolutionize how we personalize cancer care.

[NASA Science @NASAScience_]

#DYK bone marrow is one of the organs most sensitive to radiation?

AVATAR heading to deep space will contain bone marrow cells from @NASAArtemis II crew. Insights could advance personalized medicine, for both astronauts in space and patients on Earth. https://t.co/keWrejow2h

[Emulate, Inc. @emulateinc]

Organ-Chips are boldly going where no chip has gone before! Emulate is teaming up with @NASAScience_ and @space_tango to support a first-of-its-kind experiment to send Organ-Chips into deep space aboard the Artemis II. Learn all about the program here: https://t.co/FfcPgNkQWq

[NASA Science @NASAScience_]

AVATARs for astronaut health are heading to deep space! 🧑🏽‍🚀

Organ chips containing @NASAArtemis II crew cells will fly side-by-side with astronauts around the Moon. The goal: understand the impacts of deep space radiation and microgravity on individual health. 🔗 https://t.co/3Je1d57j8R

[Emulate, Inc. @emulateinc]

Regulators are calling for human-relevant data. 📊

Our CEO Jim Corbett shares how the new AVA™ Emulation System delivers scale + reproducibility to support FDA submissions and usher in a new era of #DrugDiscovery.

👉 Read more: https://t.co/HXBrbNUMv0

[Emulate, Inc. @emulateinc]

In our latest #blog, we're talking about the key US policy moves that are positioning #OrganChips and other New Approach Methodologies (#NAMs) to become the default alternatives to animal testing in drug development.

https://t.co/hkv4XYjJJZ

#drugdiscovery #sciencepolicy

[Emulate, Inc. @emulateinc]

This study revealed that cannabinoids have distinct, dose-dependent hepatotoxicity profiles, highlighting the importance of human-relevant models for cannabinoid safety evaluation.

Read the full paper here: https://t.co/jlYTzo1ued

[Emulate, Inc. @emulateinc]

New publication alert! We’re excited to share the results of a recent collaboration with @Herbalife, now published in @SciReports!

Using Emulate’s Quad-Culture Liver-Chip S1, this study explored the #hepatotoxicity potential of four common #cannabinoids—CBD, CBG, CBN, and CBC.

[Emulate, Inc. @emulateinc]

Previous animal studies had conflicting or inconclusive results on the hepatotoxicity of cannabinoids; some showed no effects, while others showed signs of toxicity at high doses.

[Emulate, Inc. @emulateinc]

The newest edition of the Emulate Community Publications Digest is live! We're spotlighting all the recent research from our user community, from patient-matched cancer models to spinal cord chips for modeling sporadic ALS. Download your copy today! https://t.co/aZd6tPIwDV

[Emulate, Inc. @emulateinc]

*to the tune of "War, what is it good for?*

NAMS!
What are they good for?
Absolutely EVERYTHING!

Check out our latest blog post to learn what #NAMs are and how they're driving a new era of human-relevant decision-making in #drugdiscovery and development!
https://t.co/3mrfvVOLh7

[Emulate, Inc. @emulateinc]

Built-in incubation, automated imaging, and AI-ready data generation deliver in vivo fidelity at scale.

Meet AVA: https://t.co/Z1jOwC9PhJ

[Emulate, Inc. @emulateinc]

ICYMI: This month, we heralded in the future of human-centric drug development with the launch of the AVA Emulation System, a first-of-its-kind high-throughput Organ-Chip platform. https://t.co/jLIZyiRE5U

[Emulate, Inc. @emulateinc]

🧠 We're only 5 days away from our next webinar! Join us on May 27 as Dr. Clive Svendsen from Cedars-Sinai presents his work using Organ-Chips and iPSCs to model multiple neurological diseases, including ALS, Parkinson’s disease, and FTD. Register now! https://t.co/EGs2ovaUVa

[Emulate, Inc. @emulateinc]

A new era of drug development: Read our latest press release to learn why we believe the FDA's groundbreaking plan to reduce #animaltesting is a pivotal step forward for patients, researchers, and the entire healthcare ecosystem.

https://t.co/bUSuJL4uzS